AU5082779A - Substituted bis-benzimidazolyl compounds and their use in treating protozoal or virus diseases - Google Patents

Substituted bis-benzimidazolyl compounds and their use in treating protozoal or virus diseases

Info

Publication number
AU5082779A
AU5082779A AU50827/79A AU5082779A AU5082779A AU 5082779 A AU5082779 A AU 5082779A AU 50827/79 A AU50827/79 A AU 50827/79A AU 5082779 A AU5082779 A AU 5082779A AU 5082779 A AU5082779 A AU 5082779A
Authority
AU
Australia
Prior art keywords
atoms
formula
denotes
see diagramm
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU50827/79A
Inventor
Wolfgang Raether
Manfred Rosner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of AU5082779A publication Critical patent/AU5082779A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/195—Radicals derived from nitrogen analogues of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/20—Two benzimidazolyl-2 radicals linked together directly or via a hydrocarbon or substituted hydrocarbon radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

(For Contracting States : BE, CH, DE, FR, GB, IT, NL) 1. Substituted bis-benzimidazolyl compounds of the general formula I see diagramm : EP0009163,P13,F1 and their physiologically compatible salts, in which A denotes 2,5-thiophenediyl, 2,5-furanediyl, p-phenylene, m-phenylene or 4,4'-phenoxyphenylene, and in which R**1 is represented by one of the general formulae IIa or IIb see diagramm : EP0009163,P14,F2 in which the radicals R**2 to R**4 independently of one another denote hydrogen, alkyl with 1-18 C atoms, cycloalkyl with 5-8 atoms, aminoalkyl, N-alkylaminoalkyl or N,N-dialkylaminoalkyl, in which an alkyl group in each case has 1-4 C atoms, morpholinoethyl, methoxyethyl, ethoxyethyl, benzyl, phenethyl or phenyl, or in which the radicals R**2 and R**3 together denote an alkylene bridge with 4, 5 or 6 CH2 groups, and in which Y denotes O, S, NH or N-R**5, in which R**5 represents alkyl with 1-4 C atoms. (For Contracting State AT) 1. Process for the manufacture of substituted bis-benzimidazolyl compounds of the general formula I see diagramm : EP0009163,P15,F1 and their physiologically compatible salts, in which A denotes 2,5-thiophenediyl, 2,5-furanediyl, p-phenylene, m-phenylene or 4,4'-phenoxyphenylene, and in which R**1 is represented by one of the general formulae IIa or IIb see diagramm : EP0009163,P15,F2 in which the radicals R**2 to R**4 independently of one another denote hydrogen, alkyl with 1-18 C atoms, cycloalkyl with 5-8 atoms, aminoalkyl, N-alkylaminoalkyl or N,N-dialkylaminoalkyl, in which an alkyl group in each case has 1-4 C atoms, morpholinoethyl, methoxyethyl, ethoxyethyl, benzyl, phenethyl or phenyl, or in which the radicals R**2 and R**3 together denote an alkylene bridge with 4, 5 or 6 CH2 groups, and in which Y denotes O, S, NH or N-R**5, in which R**5 represents alkyl with 1-4 C atoms, which comprises a) reacting a compound of the formula III R**6-A-R**6 in which A has the meanings indicated above and in which R**6 denotes see diagramm : EP0009163,P15,F3 in which Z denotes O or S and R**7 denotes alkyl or alkoxyalkyl with, in each case, 1 to 4 C atoms per alkyl radical, with a compound of the formula IV see diagramm : EP0009163,P15,F4 in which R**1 has the meanings indicated by the formula IIa or IIb, or b) reacting a compound of the general formula V see diagramm : EP0009163,P15,F5 in which A has the meanings indicated above and in which R**6 has the meanings indicated under a) under formula III, with an amine of the formula VIa or VIb see diagramm : EP0009163,P15,F6 in which R**2, R**3 and Y have the meanings indicated under formula IIa or IIb, and optionally converting a compound of the formula I, which is thus obtained, into its salt by adding a physiologically compatible acid HX, or converting a salt of the formula I, which is thus obtained, into a compound of the formula I by adding a base.
AU50827/79A 1978-09-14 1979-09-13 Substituted bis-benzimidazolyl compounds and their use in treating protozoal or virus diseases Abandoned AU5082779A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19782839989 DE2839989A1 (en) 1978-09-14 1978-09-14 SUBSTITUTED BISBENZIMIDAZOLYL COMPOUNDS, THEIR PRODUCTION AND THEIR USE
DE28399895 1978-09-14

Publications (1)

Publication Number Publication Date
AU5082779A true AU5082779A (en) 1980-03-20

Family

ID=6049430

Family Applications (1)

Application Number Title Priority Date Filing Date
AU50827/79A Abandoned AU5082779A (en) 1978-09-14 1979-09-13 Substituted bis-benzimidazolyl compounds and their use in treating protozoal or virus diseases

Country Status (8)

Country Link
EP (1) EP0009163B1 (en)
JP (1) JPS5540689A (en)
AT (1) ATE1285T1 (en)
AU (1) AU5082779A (en)
DE (2) DE2839989A1 (en)
ES (2) ES483990A1 (en)
IL (1) IL58237A0 (en)
ZA (1) ZA794864B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7858807B2 (en) 2005-08-23 2010-12-28 Ube Industries, Ltd. Method for producing 1-substituted-5-acylimidazole compound

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5667975A (en) * 1994-05-06 1997-09-16 The University Of North Carolina Method of fluorescent detection of nucleic acids and cytoskeleton elements using bis-dicationic aryl furans
US5643935A (en) * 1995-06-07 1997-07-01 The University Of North Carolina At Chapel Hill Method of combatting infectious diseases using dicationic bis-benzimidazoles
US5935982A (en) * 1997-02-28 1999-08-10 The University Of North Carolina At Chapel Hill Methods of treating retroviral infection and compounds useful therefor
WO1999026933A1 (en) * 1997-11-26 1999-06-03 Axys Pharmaceuticals, Inc. Substituted amidinoaryl derivatives and their use as anticoagulants
WO1999026932A1 (en) * 1997-11-26 1999-06-03 Axys Pharmaceuticals, Inc. By amidino group substituted heterocyclic derivatives and their use as anticoagulants
WO2005033065A1 (en) * 2003-09-05 2005-04-14 University Of North Carolina At Chapel Hill Novel amidine compounds for treating microbial infections
EP3710442A2 (en) 2017-11-17 2020-09-23 The Scripps Research Institute Bis-benzimidazole compounds and methods of using the same
CN109369612A (en) * 2018-12-17 2019-02-22 桂林理工大学 A kind of aryl radical precursor molecule of symmetrical configuration and preparation method thereof
CN109651370A (en) * 2018-12-17 2019-04-19 桂林理工大学 A kind of purine analog derivative free radical precursor molecule and preparation method thereof
USD976707S1 (en) * 2020-09-30 2023-01-31 Guangdong Industry Polytechnic Bottle

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL134833C (en) * 1960-08-11
DE1645944A1 (en) * 1965-12-06 1971-05-13 Dynachim Sarl Fungicide
DE2711362A1 (en) * 1977-03-16 1978-09-21 Hoechst Ag Bis-benzimidazole derivs. - useful as antiparasitic and antiviral agents

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7858807B2 (en) 2005-08-23 2010-12-28 Ube Industries, Ltd. Method for producing 1-substituted-5-acylimidazole compound

Also Published As

Publication number Publication date
ES483990A1 (en) 1980-05-16
JPS5540689A (en) 1980-03-22
EP0009163A3 (en) 1980-04-16
IL58237A0 (en) 1979-12-30
EP0009163B1 (en) 1982-06-30
ATE1285T1 (en) 1982-07-15
DE2963244D1 (en) 1982-08-19
EP0009163A2 (en) 1980-04-02
ZA794864B (en) 1980-08-27
ES483994A1 (en) 1980-05-16
DE2839989A1 (en) 1980-04-03

Similar Documents

Publication Publication Date Title
AU5082779A (en) Substituted bis-benzimidazolyl compounds and their use in treating protozoal or virus diseases
IL74223A (en) Hydroxyalkyl carbamate-containing resins for cathodic electrodeposition
DK178782A (en) N-SUBSTITUTED 2,4-DIALCOXYBENZENESULPHONAMIDES
DK498889A (en) SUBSTITUTED AROMATIC RELATIONS WITH EFFECT ON THE CENTRAL NERVOUS SYSTEM
DK156899C (en) PROCEDURE FOR THE PREPARATION OF BASIC SUBSTITUTED PHENYL ACETONITRILS
PH20465A (en) Substituted 6 aryl 1,2,4 triazolo 4,3-b pyridazines
SE8102985L (en) PROCEDURE FOR THE PREPARATION OF N- (2 - (((5- (DIALKYLAMINO) -METHYL-2-FURANYL) -METHYL) -TIO) -ETHYL) -N'-ALKYL-2-NITRO-1,1-ETHENIAMINES AND THEREOF THE PRODUCTS
ATE17847T1 (en) SALTS OF BIS-GUANIDIN COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MICROBICIDES.
PT70697A (en) PROCESS FOR THE PREPARATION OF IMIDAZO AND PYRIMIDO-PYRIDO-INDOLES
DE68910090D1 (en) Use of heterocyclic amides to prevent tumor metastasis.
DK572084A (en) BISAMIDE INDIPHENYLE DERIVATIVES, PROCEDURES FOR PREPARING THEREOF AND THEIR USE AS CHEMOTHERAPEUTICS
DE69107207D1 (en) DISULFID DERIVATIVES OF MERCAPTO ACYL AMINIC ACIDS.
FI833150A0 (en) PROPYLAMINDERIVAT, FOERFARANDE FOER DERAS FRAMSTAELLNING, PHARMACEUTICAL PREPARAT INNEHAOLLANDE DESSFOERENINGAR OCH DERAS THERAPEUTIC ANVAENDNING
GB1325787A (en) 6-aminomethyl-pyrimidines and a process for their production